Correction to: Nature Medicine https://doi.org/10.1038/s41591-019-0349-y, published online 11 February 2019.
In the version of this article originally published, the graph in Extended Data Fig. 2c was a duplication of Extended Data Fig. 2b. The correct version of Extended Data Fig. 2c is now available online.
Original and Corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhao, J., Chen, A.X., Gartrell, R.D. et al. Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nat Med 25, 1022 (2019). https://doi.org/10.1038/s41591-019-0449-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-019-0449-8
This article is cited by
-
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response
npj Precision Oncology (2024)
-
Machine learning-based investigation of regulated cell death for predicting prognosis and immunotherapy response in glioma patients
Scientific Reports (2024)
-
PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma
Journal of Neuro-Oncology (2022)
-
A comparative study of the recent most potent small-molecule PD-L1 inhibitors: what can we learn?
Medicinal Chemistry Research (2021)
